learndrugs
Mental & Behavioral Health

Alcohol Use Disorder & Withdrawal

AUD High-yield Verified · Sep 2026

Alcohol withdrawal is the syndrome of symptoms — tremor, anxiety, autonomic hyperactivity, and in severe cases seizures and delirium — that follows sudden cessation of, or a sharp reduction in, heavy and prolonged alcohol use.

The withdrawal nobody planned for: roughly half of people with alcohol use disorder who stop suddenly will withdraw, and hospital admission is exactly such a stop. Master the hour-by-hour timeline, the CIWA-Ar loop, and the thiamine rule.

What’s going wrong in the body

The normal physiology, where it fails, and why the body’s compensation backfires.

01 The neuroadaptation see-saw

Alcohol stimulates GABA, the brain’s main inhibitory transmitter. With chronic heavy use, the brain compensates for that constant sedation by upregulating glutamate, its main excitatory transmitter. The result is a new equilibrium — level only as long as alcohol keeps pressing the inhibitory side down. On the disorder side, ethanol also alters the reward pathway: it inhibits opioid binding at mu-opioid receptors, and long-term use upregulates those receptors, which modulate alcohol-induced dopamine release and drive craving.

When alcohol suddenly stops, the GABA signal is abruptly diminished while the upregulated glutamate remains — an unopposed excitatory excess. That excess glutamate produces the autonomic hyperactive state of withdrawal: tremor, tachycardia, hypertension, sweating, agitation, and a lowered seizure threshold. And withdrawal worsens with repetition — kindling means each subsequent withdrawal episode is progressively more severe and more seizure-prone, which is why "how many times have you withdrawn before?" is itself a risk question.

The see-saw: chronic alcohol suppression is met by glutamate upregulation; remove the alcohol and unopposed excitation swings the brain into hyperactivity.

02 The timeline: a ladder climbed in hours

Withdrawal unfolds on a clock that starts at the last drink. Early symptoms begin 6–24 hours after cessation — the earliest often within 6–12 hours: anxiety, tremor, irritability, sweating, tachycardia, elevated blood pressure, hyperactive reflexes, nausea, anorexia, headache, insomnia, palpitations, craving. Alcoholic hallucinosis develops within 12–24 hours — primarily auditory hallucinations with a clear sensorium (the patient knows where they are), usually subsiding within about 48 hours. Withdrawal seizures can occur within 6 to 48 hours after the last drink. Delirium tremens most often appears at 48–96 hours, and the risk window extends to about day 8.

Two caveats keep this ladder honest. First, not every patient climbs it in order — a withdrawal seizure often arrives with no other signs of withdrawal at all, and more than 90% of these seizures come within 48 hours of the last drink. Second, consider another cause if the seizure is focal, if there is trauma or fever, if there is no alcohol history, or if the last drink was more than 48 hours earlier; a seizure with a likely alternative cause warrants further evaluation such as EEG or imaging, because plenty of look-alikes — hypoglycemia, DKA, thyrotoxicosis, CNS infection, intracranial hemorrhage, stimulant use, sedative-hypnotic withdrawal, hepatic encephalopathy — mimic this picture.

The withdrawal ladder, in hours after the last drink. The dotted path is the warning: stages do not always run in order — a seizure can arrive with little warning.

03 Delirium tremens: the storm at the top

Only 3–5% of patients with withdrawal progress to delirium tremens (DT) — but roughly half of people with AUD who abruptly stop or reduce drinking will experience some withdrawal, so the at-risk pool is enormous: 29.5 million Americans aged 12 and older have AUD (only 7.6% receive treatment), and 15–25% of patients entering hospitals have alcohol dependence or high-risk drinking.

DT is the most severe form of withdrawal: a rapid-onset, fluctuating disturbance of attention and cognition — true delirium and disorientation — plus hallucinations and severe autonomic hyperactivity: fever, severe tachycardia, hypertension, drenching sweats, and agitation. This is what separates DT from the hallucinosis rung below it: hallucinosis happens in a clear sensorium; DT is a clouded, fluctuating one. Untreated, DT historically killed up to 20% of patients; with modern management mortality is roughly 1–5% — a number that low only because it is treated as the emergency it is.

04 Why it strikes in the hospital — and how CIWA-Ar catches it

Hospitalization means abrupt, unplanned cessation. A patient admitted for elective surgery who drinks daily — and never mentioned it, as many patients do not — stops cold at admission. Run the timeline math: seizures at 6–48 hours, DT at 48–96 hours, and the "mystery" agitation, tremor, and tachycardia land on hospital day 2–4, right when the team is blaming pain, anxiety, or anesthesia. This is why universal screening and "when was your last drink?" belong in every admission history: the time elapsed since the last drink defines the risk window still ahead.

Once withdrawal is recognized, management runs on a loop, not a schedule. The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) scores 10 symptom domains; symptom-triggered dosing medicates to the score rather than the clock, and it has been linked to less total benzodiazepine use and a shorter course of treatment. Two limits matter. First, CIWA-Ar grades severity once the diagnosis is made — it cannot tell you whether the symptoms are withdrawal at all. Second, it needs a patient who can talk: 6 of its 10 items require the patient to answer questions, it was designed for voluntary detox centres, and it has not been validated in critically ill, medically complex or postoperative patients (in one ICU study it could not be scored in 44% of patients because they were intubated). The modified MINDS (mMINDS) fills that gap — it scores what the nurse can observe (pulse, blood pressure, tremor, sweating, hallucinations, agitation, orientation, delusions, seizures) without asking the patient anything, and it has been validated in medical ICU patients.

The CIWA-Ar loop: score, dose to the score, reassess, repeat — medication follows measured severity instead of a fixed schedule.

Causes & risk factors

Modifiable factors are teaching targets — the patient can act on them.

Ongoing heavy, regular alcohol use — the modifiable root cause modifiable Prior withdrawal delirium or withdrawal seizure (the strongest predictors) Numerous prior withdrawal episodes — kindling Long duration of heavy regular drinking Age over 65 Coexisting medical illness Physiologic dependence on benzodiazepines

Signs & symptoms

Each finding tied to the mechanism that produces it — and the triage it calls for.

Tremor, anxiety, irritability — starting 6–24 h after the last drink early Expected
Why: The GABA signal drops away while upregulated glutamate keeps firing — the first visible edge of CNS excitation.
Tachycardia, elevated blood pressure, sweating, palpitations early Expected
Why: Adrenergic hyperactivity: the glutamate excess drives the autonomic hyperactive state of withdrawal.
Nausea, anorexia, vomiting early Hold & notify
Why: Part of the early withdrawal cluster — and vomiting or diarrhea makes unassisted trips to the bathroom a fall risk.
Insomnia, headache early Expected
Why: Sleep architecture rebounds against chronic sedation; these begin within the same 6–24 h window.
Hyperactive reflexes early Expected
Why: CNS excitation writ large — brisk reflexes track the hyperexcitable state.
Craving early Expected
Why: Long-term ethanol upregulates mu-opioid receptors that modulate alcohol-induced dopamine release — the reward pathway demanding its input back.
Auditory hallucinations with a clear sensorium (12–24 h) Hold & notify
Why: Alcoholic hallucinosis: the patient hears things but knows where they are and can converse — this clear sensorium distinguishes it from DT. Affects ~2% of withdrawal patients.
Withdrawal seizure (6–48 h) Report immediately
Why: The lowered seizure threshold gives way. A seizure can come early — "within just a few hours of alcohol cessation" — and kindling raises the seizure risk with every successive withdrawal.
New confusion, clouded sensorium, inability to follow instructions late Report immediately
Why: The herald of delirium tremens: altered mental status on top of autonomic signs is delirium, not hallucinosis. This is the moment to escalate, not observe.
Fever, severe tachycardia, hypertension, drenching sweats, extreme agitation (48–96 h) late Report immediately
Why: Delirium tremens in full: severe autonomic hyperactivity plus fluctuating delirium and hallucinations — mortality ~1–5% even with treatment.
Withdrawal symptoms while blood alcohol is still detectable Hold & notify
Why: A positive blood alcohol level does not exclude withdrawal — significant withdrawal can begin before the alcohol is gone.
Confusion + ataxia + eye-movement abnormalities (nystagmus, ophthalmoplegia) Report immediately
Why: The Wernicke encephalopathy triad from thiamine deficiency — but only ~16% of patients show all three, so any one of them in a drinker demands thiamine now.
Over-sedation or slowed breathing on benzodiazepine therapy Hold & notify
Why: Aggressive benzodiazepine dosing is a mainstay of treatment; the cost of that necessity is close monitoring for over-sedation and respiratory depression.

Diagnostics

Test In this disorder Normal
CIWA-Ar score A severity and dosing tool used once the diagnosis is established — not a diagnostic one. Most items depend on the patient answering questions, and it is not validated in critically ill, medically complex or postoperative patients; a head injury can also falsely raise the score. Mild ≤ 8 · moderate 8–15 · severe > 15. Scores below 10 typically need no medication, and treatment thresholds vary by agency protocol StatPearls / Open RN 0 (10 items, each 0–7 except orientation 0–4; max 67)
Diagnosis (clinical + DSM-5) History and physical make this diagnosis — it is a clinical diagnosis, and no single lab confirms or excludes it. Withdrawal, withdrawal delirium, and AUD are diagnosed clinically by DSM-5 criteria. AUD = ≥ 2 of 11 criteria in 12 months: mild 2–3 · moderate 4–5 · severe ≥ 6 DSM-5 / StatPearls —
Blood alcohol concentration Send a urine toxicology screen too — concomitant substance use can mimic or coexist with withdrawal. A positive BAC does not rule out withdrawal — significant withdrawal can occur while alcohol is still detectable Michigan Medicine MAWS protocol —
BMP/CMP + magnesium + phosphorus Hypophosphatemia flags refeeding-syndrome risk, and magnesium deficiency undermines thiamine use. Hospital protocols add folic acid and a daily multivitamin, since these patients are often nutritionally deficient. Check and replete electrolytes — magnesium and phosphorus especially StatPearls / MAWS protocol —
Hepatic panel, CBC + markers of use Baseline work-up also includes a CBC with differential and a urine pregnancy test in women. AST, ALT, and GGT elevations mark chronic use; ethyl glucuronide detects use ~5 days back, carbohydrate-deficient transferrin ~2 weeks, phosphatidylethanol ~3 weeks StatPearls / MAWS protocol —
AUD screening (AUDIT · AUDIT-C · SASQ · CAGE) USPSTF grade B: screen all adults with a validated brief instrument (SASQ or AUDIT-C). CAGE is still used but no longer preferred — better tests exist. Screening matters because many patients never volunteer their alcohol history. AUDIT ≥ 8 may indicate AUD; CAGE ≥ 2 "yes" answers (Cut down · Annoyed · Guilty · Eye-opener) may signal AUD — cutoff of 1 for older adults USPSTF / MedlinePlus —

Complications

Warning: Withdrawal seizures Report immediately
Can occur within 6–48 h after the last drink — sometimes within just a few hours.
Consider another cause if the seizure is focal, if there is trauma or fever, or if the last drink was more than 48 hours earlier; a seizure with a likely alternative cause warrants further evaluation such as EEG or imaging. After a withdrawal seizure, another can follow: these seizures usually come singly or in brief clusters, and in a trial of adults with a witnessed withdrawal seizure, placebo carried a much higher risk of a recurrent seizure within six hours than a single IV lorazepam dose — benzodiazepines reduce recurrence. Phenytoin "has not been shown to be effective or safe in preventing recurrent alcohol withdrawal seizures."
Warning: Delirium tremens Report immediately
Fluctuating delirium + hallucinations + autonomic storm (fever, severe tachycardia, hypertension, drenching sweats) at 48–96 h — historically up to 20% mortality untreated, ~1–5% with treatment.
Heralded by new confusion or disorientation on top of autonomic signs. The nurse’s move: escalate now — severe withdrawal is treated in a monitored setting, with adequate IV access for medication, fluids and electrolytes, and aggressive benzodiazepine dosing with sedation, respiratory rate and oxygen saturation checked around each dose.
Warning: Wernicke encephalopathy → Korsakoff syndrome Report immediately
Thiamine (B1) deficiency — alcohol impairs its intake, absorption, storage, and activation. Triad: confusion, ataxia, ophthalmoplegia — but only ~16% show all three and ~19% show none at first; mortality ≈ 17%.
Untreated Wernicke progresses to Korsakoff syndrome in ~80% of survivors — a chronic, largely irreversible amnestic disorder with confabulation. Prevention is cheap and yours to guard: IV/IM thiamine (oral absorption is unreliable), and never dextrose without thiamine in this population.
Caution: Alcoholic ketoacidosis & refeeding risk Hold & notify
An anion-gap metabolic acidosis of the malnourished drinker; hypophosphatemia signals refeeding-syndrome risk as nutrition resumes.
Alcoholic ketoacidosis is treated with glucose-containing fluid (such as D5-NS) — with thiamine on board. Track and replete magnesium and phosphorus before and during refeeding.
Caution: Over-sedation on high-dose benzodiazepines Hold & notify
Aggressive dosing risks over-sedation and respiratory depression; large amounts of IV lorazepam can also cause metabolic acidosis from its propylene glycol diluent.
Check sedation, respiratory rate and oxygen saturation before and an hour after each dose; hold the dose for moderate or deeper sedation, a respiratory rate under 10, or oxygen saturation under 90%, and report over-sedation immediately.

Medications for this condition

Why each class is prescribed here — every card links to its full pharmacology page.

Benzodiazepines First-line
Nervous · diazepam

First-line therapy for alcohol withdrawal, because they are the most effective agents at preventing complications such as seizures and delirium and at reducing withdrawal severity. The logic is cross-tolerance: benzodiazepines enhance GABA signaling, substituting for alcohol’s lost inhibitory push against the glutamate excess. Diazepam is a common first choice for its rapid onset and long duration, and chlordiazepoxide is a long-acting front-loading agent; when liver disease is a concern, lorazepam — with minimal hepatic metabolism — is used instead, and older adults need lower doses or longer intervals. Dose symptom-triggered to the withdrawal score, and expect aggressive dosing with close monitoring in severe withdrawal.

Beyond medications

  • Low-stimulation environment — a calm, dimly lit room with minimal outside disturbances, plus reassurance. In ambulatory withdrawal, a support person at home monitors symptoms, manages medications, and keeps in touch with the care team.
  • Nutritional repletion — thiamine 100 mg daily, preferably IV or IM because oral absorption is unreliable, with folic acid and a daily multivitamin (one hospital protocol continues these for 7–14 days), given before or with any dextrose; magnesium and phosphorus repletion.
  • Safety measures — fall-risk assessment (GI symptoms make unassisted bathroom trips a fall hazard), adequate IV access for medication, fluids and electrolytes, and sedation, respiratory-rate and oxygen-saturation checks around every benzodiazepine dose.
  • Structured monitoring — reassess on the protocol’s schedule — frequent assessment is part of safe benzodiazepine use — and keep watching at-risk patients through the 6–36 hour window in which early withdrawal appears.
  • Treat the AUD, not just the withdrawal — diagnosing and addressing the underlying AUD matters most: medication can often be started before discharge, with outpatient follow-up arranged and recovery supports such as 12-step groups offered.
  • Maintenance pharmacotherapy referral — three FDA-approved options: naltrexone (first-line; blocks alcohol’s reinforcing effects; avoid with opioid use), acamprosate (first-line; contraindicated in renal failure), and disulfiram (aversive; avoid in cardiac or hepatic disease).

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Assessment & monitoring
Ask "when was your last drink?" — and how much, how long, and any prior withdrawals, seizures, or DTs — on every admission.
Why: Time since the last drink defines the risk window still ahead of you. 15–25% of admitted patients drink at dependence levels, most won’t volunteer it, and admission is an abrupt stop — the day 2–4 "mystery agitation" is preventable only if you know the clock started.
Score the withdrawal scale on the protocol’s schedule — more often while symptoms are active — and keep observing at-risk patients through the 6–36 hour window in which early withdrawal appears.
Why: Symptom-triggered treatment lives and dies by the reassessment loop — the score is the dose trigger, and a lengthening gap between scores is how early DT gets missed.
Treat unexplained tremor + tachycardia + hypertension + agitation on hospital day 2–4 as withdrawal until proven otherwise — especially post-op.
Why: Seizures run 6–48 h and DT 48–96 h after the last drink; the timeline math lands squarely on post-op day 2–3, where it hides behind pain and anesthesia.
Know what mimics and what coexists: hypoglycemia, DKA, thyrotoxicosis, CNS infection, other substances, and sedative-hypnotic withdrawal all impersonate the syndrome.
Why: CIWA-Ar grades severity once the diagnosis is made — it cannot tell you whether the symptoms are withdrawal at all.
Track magnesium, phosphorus, and glucose; flag hypophosphatemia before feeding resumes.
Why: Chronic alcohol use depletes magnesium (which compounds thiamine deficiency) and phosphorus; low phosphorus is the refeeding-syndrome warning light.
Once a patient can no longer answer the CIWA-Ar questions (severe withdrawal, intubation), switch to a scale that does not rely on self-report, such as the modified MINDS (mMINDS).
Why: Six of the ten CIWA-Ar items require the patient to answer questions, so the scale leans on subjective report and may not be usable in more severe withdrawal — exactly when severity peaks. mMINDS does not require the patient to answer questions and has been validated in medical ICU patients.
During severe withdrawal & DT
Give symptom-triggered benzodiazepines per the CIWA-Ar protocol and reassess within the ordered window.
Why: Dosing to the score has been linked to less total benzodiazepine and a shorter course of treatment than fixed schedules.
Give thiamine before or with any dextrose — never glucose loading alone in a patient with chronic alcohol use.
Why: Glucose oxidation consumes thiamine, and an infusion into a depleted patient can precipitate Wernicke encephalopathy.
Keep the room dimly lit and quiet; approach calmly and reassure; cluster care to limit stimulation.
Why: A hyperexcitable brain amplifies every stimulus; a calm environment with minimal outside disturbances is part of standard withdrawal care.
Escalate immediately for: seizure, new confusion or hallucinations, over-sedation or slowed breathing, or unstable vital signs.
Why: Each marks progression toward seizure, delirium, or a treatment complication — the points at which the level of care must rise.
For DT: anticipate care in a monitored setting, keep adequate IV access, and check sedation, respiratory rate and oxygen saturation around every dose.
Why: DT kills ~1–5% even treated — deaths are attributed to cardiovascular complications, hyperthermia, aspiration, and severe fluid and electrolyte disorders — and the aggressive benzodiazepine dosing it demands requires someone watching the airway.
Hold the benzodiazepine dose for moderate or deeper sedation, a respiratory rate under 10, or oxygen saturation under 90%, and notify the provider.
Why: Respiratory depression and over-sedation are the treatment’s failure modes, and the hold parameters exist to catch them early.
Question any order that uses clonidine or an antipsychotic as the only treatment for withdrawal.
Why: These are adjuncts for symptoms that persist despite benzodiazepines — never monotherapy. Haloperidol can mask withdrawal severity and raise seizure propensity, which is why it is not recommended in the first 72 hours.
Patient teaching & the road out
Walk the patient (and family) through what to expect: the symptom timeline, how each stage is treated, and which symptoms mean "call or come back now" — seizures, fever, hallucinations, or new confusion.
Why: Knowing the course reduces fear-driven relapse and gets ambulatory patients back before the 48–96 h DT window closes on them at home.
Teach benzodiazepine safety: no alcohol and no other CNS depressants while taking them, and report drowsiness or slowed breathing.
Why: Combining CNS depressants risks respiratory depression.
Frame withdrawal management as the first step: arrange outpatient follow-up for the AUD itself and offer recovery supports, including 12-step groups.
Why: Addressing the underlying AUD — often by starting a medication before discharge — reduces 30-day readmission; without it, the next admission is the same admission.
Discuss maintenance medication options — naltrexone, acamprosate, disulfiram — with the provider before discharge.
Why: Three FDA-approved medications exist and only 7.6% of people with AUD receive any treatment; the discharge conversation is where that number changes.
For home (ambulatory) withdrawal: identify a support person who can monitor symptoms, manage medications and contact the care team — and bring the patient back for any warning sign.
Why: Ambulatory withdrawal succeeds only with that support person — family are the monitoring system at home.

How a real nurse thinks

The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.

  1. 1
    Recognize cues

    The cluster that matters: new bilateral tremor, HR 118 with BP 162/94 and diaphoresis, restlessness with startle, insomnia, nausea, low-grade temperature — on post-op day 2, with pain controlled at 3/10. Add the labs: magnesium 1.2 and elevated AST/ALT/GGT, the fingerprint of chronic alcohol use. The "social drinker" admission note is a cue too — of a question that was never really asked.

  2. 2
    Analyze cues

    Pain at 3/10 doesn’t produce tremor, drenching sweats, and startle. This is autonomic hyperactivity, and the timeline fits: admission stopped his drinking cold ~60 hours ago — at the edge of the seizure window (6–48 h, so mostly behind him, though not certainly) and squarely inside the DT window (48–96 h). His sensorium is still clear — he is oriented ×4 — so this is withdrawal not yet progressing to delirium. Differentials worth a glance (hypoglycemia, infection) don’t explain the whole cluster; the elevated liver markers and low magnesium do.

  3. 3
    Prioritize

    The priority is preventing seizures and DT in the hours ahead, not just treating tonight’s numbers. That means: establish the history and severity score first (it drives everything), get the provider engaged for symptom-triggered treatment, protect the brain — thiamine is not yet on board and dextrose is already infusing — and replete the magnesium that both compounds thiamine deficiency and travels with withdrawal seizures.

  4. 4
    Generate solutions

    Ask directly and without judgment when his last drink was and about prior withdrawals or seizures; score CIWA-Ar now and put it on the protocol’s reassessment schedule. SBAR the provider: post-op day 2, last drink ~60 h ago, CIWA-Ar score, magnesium 1.2, D5-containing fluid running with no thiamine ordered — anticipate symptom-triggered benzodiazepine orders, IV thiamine before or with the continuing dextrose, and magnesium repletion. Move him toward a quiet, evenly lit room; institute fall and safety measures with resuscitative equipment checked nearby.

  5. 5
    Take action

    He confirms daily drinking and a prior "rough detox." CIWA-Ar scores 12 — moderate. Deliver the SBAR and implement the new orders: IV thiamine given with the running dextrose, symptom-triggered lorazepam-class dosing per protocol (his AST/ALT/GGT elevation is exactly why a benzodiazepine with minimal hepatic metabolism appeals here), IV magnesium, frequent CIWA-Ar reassessment, quiet room, bathroom assistance, no unassisted ambulation. Tell him what’s happening and what to expect — reassurance is itself a treatment in a hyperexcitable brain.

  6. 6
    Evaluate

    Success over the next 24–36 h: CIWA-Ar trending down below 10, the level that typically needs no medication, vitals settling, sleep returning, sensorium staying clear, no seizure. Escalate immediately for: seizure, hallucinations, new confusion or fluctuating attention (the DT herald), or over-sedation. Before discharge: the AUD conversation, warm handoff, and maintenance-medication options.

Scenario — you’re the nurse

Work each question before revealing the answer. Rationales explain the wrong options too.

Surgical unit · post-op day 2, 1900 assessment

A 58-year-old admitted two days ago for elective bowel resection. Admission history records "social drinker." Surgery was uncomplicated; today the day shift charted "anxious, restless — pain poorly controlled?" He is on D5½NS at 100 mL/h and has eaten little for days. His last drink, though nobody has asked, was the evening before admission — roughly 60 hours ago.

1900 vitals — HR 118 · BP 162/94 · RR 22 · T 37.8 °C · SpO₂ 95% on room air
Assessment — fine tremor of both hands; skin diaphoretic; restless, startles at noise; alert and oriented ×4
Nurse’s note — "slept < 2 h last night; states he feels shaky and sick to his stomach"
1800 labs — magnesium 1.2 mg/dL (flagged low) · phosphorus 2.4 mg/dL · AST/ALT/GGT elevated
Infusing — D5½NS at 100 mL/h · oxycodone PRN given 1400, pain now 3/10
Q1 Select all that apply
On post-op day 2 the nurse reviews the 1900 assessment. Which findings require follow-up? Select all that apply.
  1. A. New fine tremor of both hands
  2. B. HR 118 and BP 162/94 with diaphoresis
  3. C. Incision pain 3/10 after the 1400 analgesic
  4. D. Restlessness, startling at noise, < 2 h sleep
  5. E. Magnesium 1.2 mg/dL (flagged low)
  6. F. Temperature 37.2 °C recorded this morning
Reveal answer & rationale
Answer: A, B, D, E
Tremor (A), tachycardia + hypertension + diaphoresis (B), and agitation with insomnia (D) form the autonomic hyperactivity cluster of alcohol withdrawal, landing exactly in the post-op day 2–4 window that abrupt cessation at admission predicts. Low magnesium (E) travels with chronic alcohol use, compounds thiamine deficiency, and is repleted partly because of its link to withdrawal seizures. Pain controlled at 3/10 (C) is an expected, managed post-op finding — and notably fails to explain the cluster. A normal morning temperature (F) needs no action.
Q2 Multiple choice
The patient has D5½NS infusing and has eaten poorly for days. Which action best protects him from Wernicke encephalopathy?
  1. A. Ensure IV thiamine is given before or together with the dextrose-containing fluids
  2. B. Switch the fluids to plain normal saline and hold all glucose until he is eating
  3. C. Give oral thiamine with his next meal
  4. D. Hold thiamine unless confusion, ataxia, or eye findings appear
Reveal answer & rationale
Answer: A
Glucose oxidation consumes thiamine, so dextrose in a depleted chronic drinker can precipitate Wernicke encephalopathy — the rule is thiamine before or with glucose, never dextrose alone (A). Stopping glucose (B) misses the point — glucose isn’t the enemy, missing thiamine is (alcoholic ketoacidosis is actually treated with D5-containing fluid plus thiamine). Oral thiamine (C) is unreliably absorbed in this population — IV/IM is preferred. Waiting for the triad (D) gambles badly: only ~16% of Wernicke patients show all three signs and ~19% show none at first evaluation.
Q3 Put in order
Put the nurse’s first four actions in priority order:
  1. A. Notify the provider by SBAR and anticipate symptom-triggered benzodiazepine, thiamine, and magnesium orders
  2. B. Ask when his last drink was, screen for prior withdrawals and seizures, and score the CIWA-Ar
  3. C. Administer the ordered IV thiamine with the running dextrose and the first symptom-triggered dose
  4. D. Establish a quiet, evenly lit environment with fall and safety measures in place
Reveal answer & rationale
Correct order: B → A → C → D
Assessment comes first (B): the last-drink clock and the CIWA-Ar score are the data every subsequent decision — including the provider’s orders — runs on. The SBAR (A) follows immediately, because symptom-triggered treatment, thiamine, and magnesium all require orders. Then give the treatment (C) — thiamine urgency is amplified by the dextrose already infusing. The environment and safety work (D) matters and happens in parallel where possible, but it never precedes the assessment, notification, and medications that actually prevent seizures and DT. Calling the provider before scoring (A first) means calling with nothing to report.
Q4 Multiple choice
Overnight, which change would most indicate the patient is progressing to delirium tremens?
  1. A. He reports hearing voices but remains alert and oriented ×4
  2. B. New disorientation with fluctuating attention, fever, drenching sweats, and HR 140
  3. C. His bilateral hand tremor becomes more pronounced
  4. D. His CIWA-Ar score falls from 12 to 6
Reveal answer & rationale
Answer: B
DT is defined by delirium — a rapid-onset, fluctuating disturbance of attention and cognition — riding on severe autonomic hyperactivity (fever, severe tachycardia, drenching sweats), typically at 48–96 h (B). Hallucinations with a clear sensorium (A) are alcoholic hallucinosis — reportable and treatable, but the intact orientation is precisely what separates it from DT. Worsening tremor alone (C) raises the CIWA-Ar score and may trigger a dose, but doesn’t announce delirium. A falling score (D) is the treatment working — though once a patient is actually delirious, CIWA-Ar is no longer the right tool at all.
Q5 Multiple choice
The patient’s spouse asks why the lorazepam "only comes when they do that checklist" instead of on a regular schedule. The nurse’s best explanation:
  1. A. Dosing to the symptom score treats his actual withdrawal severity while using less total medication overall
  2. B. Scheduled doses would put him at risk of becoming addicted to lorazepam
  3. C. The medication is only needed if he actually has a seizure
  4. D. The score tells the team when he is ready for discharge
Reveal answer & rationale
Answer: A
Symptom-triggered dosing medicates to measured severity rather than the clock and has been linked to less total benzodiazepine use and a shorter course of treatment (A). The addiction framing (B) misstates the purpose — the schedule is about matching dose to measured severity, not about dependence. Waiting for a seizure (C) is backwards: benzodiazepines are given to prevent seizures and delirium, not to chase them. CIWA-Ar is a severity and dosing tool (D), not a discharge criterion — and not a diagnostic one either.

Common questions

What causes alcohol use disorder & withdrawal?
Common causes and risk factors include ongoing heavy, regular alcohol use — the modifiable root cause, prior withdrawal delirium or withdrawal seizure (the strongest predictors), numerous prior withdrawal episodes — kindling, long duration of heavy regular drinking, age over 65, and others.
What are the early signs of alcohol use disorder & withdrawal?
Early findings include Tremor, anxiety, irritability — starting 6–24 h after the last drink, Tachycardia, elevated blood pressure, sweating, palpitations, Nausea, anorexia, vomiting, Insomnia, headache, Hyperactive reflexes, and others.
Which findings should a nurse report immediately in alcohol use disorder & withdrawal?
Report immediately: Withdrawal seizure (6–48 h), New confusion, clouded sensorium, inability to follow instructions, Fever, severe tachycardia, hypertension, drenching sweats, extreme agitation (48–96 h), Confusion + ataxia + eye-movement abnormalities (nystagmus, ophthalmoplegia), Withdrawal seizures, and others. These signal deterioration that needs rapid intervention.
Why is thiamine given before (or with) glucose in alcohol withdrawal?
Chronic alcohol use depletes thiamine — intake, absorption, liver storage, and activation are all impaired — and glucose metabolism consumes what little remains, so a dextrose load can precipitate Wernicke encephalopathy (confusion, ataxia, eye-movement abnormalities). The classic rule: thiamine before or with glucose, never dextrose alone, and give it IV or IM because oral absorption is unreliable.
What is the difference between alcoholic hallucinosis and delirium tremens?
Sensorium. Alcoholic hallucinosis (12–24 h after the last drink) is primarily auditory hallucinations in a patient who remains alert and oriented — a clear sensorium. Delirium tremens (48–96 h) is true delirium: fluctuating attention and cognition, disorientation, hallucinations, plus severe autonomic hyperactivity (fever, severe tachycardia, hypertension, drenching sweats). New confusion on top of withdrawal signs is the DT alarm, not "more hallucinosis."
When after the last drink do delirium tremens start?
Most often 48–96 hours after the last drink — which is why an unrecognized drinker admitted to the hospital decompensates on day 2–4 — and the risk window extends to about day 8. Only 3–5% of withdrawal patients progress to DT; risk is highest with prior DTs or withdrawal seizures, many previous withdrawal episodes, older age, coexisting illness, and heavy, prolonged drinking.

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.